Orthopedic surgery has been steadily leaving the hospital for years, and that migration is picking up speed. CMS began a three-year phaseout of the Medicare inpatient-only list in 2026, starting with 285 mostly musculoskeletal procedures, pushing more joint and spine cases toward outpatient settings.
Richmond, Va.-based OrthoVirginia built its model around those settings. The group, which calls itself the largest provider of orthopedic medicine in Virginia, runs clinics and two kinds of surgical facilities, all outside the hospital.
CEO David Jevsevar, MD, arrived at the group in 2022 after working in private practice, at Intermountain Healthcare and as chair of orthopedics at Dartmouth-Hitchcock.
“I often say that we are a small musculoskeletal health system,” Dr. Jevsevar told Becker’s. “We have everything in our system except for hospitals, so we’re able to provide incredible continuity of care with focus on experience and outcome at costs that are lower, and I think all of those things are recognized by patients, and they’re also recognized by payers.”
The group’s surgical footprint includes ASCs and a second type of facility.
“We actually have two kinds of surgery centers. We have ASCs, and we also have, in our state, operatories,” Dr. Jevsevar said. “So operatories for us are licensed surgery centers, but they aren’t recognized by Medicare. So the reason why we do that is we don’t require certificates of need to build those. And Virginia is a certificate-of-need state.”
Virginia’s certificate-of-need program requires state approval for most new medical facilities and added services. OrthoVirginia performed its first hip replacement at its Westchester Operatory in Midlothian, Va., in October 2024.
Owning those sites is central to how Dr. Jevsevar defines the value of independent practice.
“I think the difference between independent practice is we are able to focus on that connection between the patient and the physician and the care that they receive. And part of that simply is we don’t have a big infrastructure of fixed costs that dictate how, when, and where we need to provide care,” he said. “So we have the optionality of providing care where we think the best care should be provided, and frequently that’s at the lowest cost side of care.”
The facilities are also where the group competes on experience.
“So especially in our operatories, but also in our ASCs, we’re able to design a patient experience that I think is unsurpassed, and I think it’s not that maybe hospitals or healthcare systems or academic medical centers don’t want to do it. They don’t have the capacity or capability to really do it at the level that we are able to do it,” Dr. Jevsevar said.
“So we can make the experience incredibly seamless,” he continued. “We can make the experience for the patient and their family really special, and if you look at our patient satisfaction scores, if we look at them compared to what we do in hospitals and what we do in our surgery centers or operatories, there’s no comparison.”
He added that as care shifts to a value-based system, his practice design delivers not only on the outcome side of the equation, but also on the cost side.
“When you’re able to get at least the same outcomes, if not better outcomes, better patient satisfaction at a lower cost, I think, by definition, you’ve improved outcome or improved value,” Dr. Jevsevar said.
But the reimbursement, especially from Medicare, does not always reflect that value. CMS’ final 2027 outpatient rule raises ASC payments 2.3% and projects a 6% increase in Medicare ASC payments for musculoskeletal procedures — but the ASC base rate falls to about 58% of the hospital rate, down from about 62% in 2026.
“I know that CMS thinks, well, maybe we’re increasing the rates slightly that we’re paying ASCs, and that’s going to offset it. It actually doesn’t offset it. That’s not the way the economics of an ASC works,” Dr. Jevsevar said. “The only reason why ASCs are profitable for us is because we take commercial patients there. If we did all Medicare and ASC, we would be upside down in it.”
Total joint replacement shows both how far the outpatient shift has come and how much room is left.
“For us in Northern Virginia, if I looked just at arthroplasty in between 2019 and 2025, 87.5% of our total hips and total knees were done inpatient. If we look at last year, only 2.5% of all our total hips and total knees were done inpatient,” Dr. Jevsevar said.
The question is where those cases went.
“Not all of those ones that were done were done in our surgery centers. Most of them were done in HOPD settings, so we still have a ways to go and to get the comfort level of physicians and our surgeons to feel comfortable taking more cases to our surgery centers,” he said. “But I do think that’s the future.”
“I think single specialty ASCs are unique in that they’re able to really be a focused factory,” Dr. Jevsevar said.
